Please login to the form below

Not currently logged in
Email:
Password:

EPO

This page shows the latest EPO news and features for those working in and with pharma, biotech and healthcare.

China first market to approve AZ’s kidney drug roxadustat

China first market to approve AZ’s kidney drug roxadustat

It is though that mechanism causes lower but more consistent EPO levels in the blood.

Latest news

More from news
Approximately 1 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.).

  • Can biosimilars live up to the hype? Can biosimilars live up to the hype?

    For instance, in Germany, an estimated 0.5bn has been saved with the introduction of Epo biosimilars and there has been a dramatic expansion in the use of the biosimilar filgrastim

  • Deal Watch February 2016 Deal Watch February 2016

    licence. 105. †† Genexine/ Shanghai Chemo WanBang Biopharma. GX-E2 (EPO-hyFc), a novel Fc-engineered (hyFc) long acting EPO, for anaemia due to chronic kidney disease and chemotherapy.

  • An eye towards the biobetter in South Korea An eye towards the biobetter in South Korea

    EPO-Fc. EPO-hybrid Fc. Anaemia. S Korea. Phase I. Hanferon (HL143). HanAll Biopharma. ... Hormone deficiency. S Korea. Phase I Completed Dec 2011. HL033. Improved EPO.

  • Country report: The healthcare market in Germany Country report: The healthcare market in Germany

    For instance, the launch of EPO has contributed to considerable public savings.OTC drugs are sold in pharmacies only (some herbal medicines and supplements can be sold in other stores) and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics